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It has been reported that mitochondrial metabolic and biophysical parameters are associated with
degenerative diseases and the aging process. To evaluate these biochemical parameters, current
technology requires several hundred milligrams of isolated mitochondria for functional assays. Here,
we demonstrate manufacturable wafer-scale mitochondrial functional assay lab-on-a-chip devices,
which require mitochondrial protein quantities three orders of magnitude less than current assays,
integrated onto 499 standard silicon wafer with new fabrication processes and materials. Membrane
potential changes of isolated mitochondria from various well-established cell lines such as human
HeLa cell line (Heb7A), human osteosarcoma cell line (143b) and mouse skeletal muscle tissue were
investigated and compared. This second generation integrated lab-on-a-chip system developed here
shows enhanced structural durability and reproducibility while increasing the sensitivity to changes in
mitochondrial membrane potential by an order of magnitude as compared to first generation
technologies. We envision this system to be a great candidate to substitute current mitochondrial
assay systems.
1 Introduction
The mitochondrial membrane potential (Dym) plays a crucial
role in the production of ATP as an energy source of the cell. The
electron transport chain (complex I, II, III, IV) positioned at the
mitochondrial inner membrane generates this electrochemical
potential gradient across the inner membrane by pumping
protons through the mitochondrial inner membrane while
sequentially transporting electrons through the complexes. This
proton gradient is utilized by ATP synthase (complex V) to
synthesize ATP from ADP and inorganic phosphate. This cycle
can remain functional and constantly produce ATP to sustain
the cell only when the electrochemical proton gradient is
maintained at a constant level with enough available ADP.
Dym is the key component of this electrochemical potential
gradient, therefore it is important to develop instrumentation
technologies to monitor Dym in order to efficiently evaluate
mitochondrial function.1
Mitochondria are known to regulate cell life and death by
control of apoptosis, through a critical, irreversible step involving
the mitochondrial permeability transition pore (mPTP), a mega-
pore complex triggered to open under certain conditions at both
the mitochondrial inner and outer membranes.2–7 Once opened,
the permeability of the mitochondrial inner membrane increases
drastically, causing the release of bioactive proteins including
cytochrome C and the inflow of protons, resulting in an
irreversible collapse of the mitochondrial membrane potential.
This process is known to lead to apoptosis. In addition,
malfunctions and abnormal behaviors of mitochondria are
highly associated with the degenerative diseases and the aging
process.8–10
A lipophilic cation such as tetraphenylphosphonium (TPP+)
diffuses through the mitochondrial inner membrane, the







By measuring the concentration of TPP+ outside the
mitochondria,[TPP+]out, using electrochemical ion selective
electrode technology, one can infer the concentration of cation
taken up into the mitochondria,[TPP+]in, to determine the
membrane potential.7 Previously, we reported on an electro-
chemical mitochondrial functional assay using a miniaturized
on-chip mitochondrial membrane potential sensor equipped with
TPP+ ion selective electrodes.11 This first generation planar-type
mitochondrial assay sensor showed good sensitivity and a fast
response to Dym by monitoring the activity of TPP
+ in the
sample solution. However, there were some challenges with the
construction process and other factors that could limit the use of
the sensor. First, the ion selective membrane was manually cut
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from a thin jelly membrane sheet on the glass substrate itself and
then individually transferred onto an open trench of PDMS
layers. This was laborious and often caused wrinkles resulting in
weak bonding between the membrane and the PDMS layer and,
subsequently, electrolyte leakage. This could lead to unstable
sensor performance and a shorter sensor lifetime. In order to
improve the production yield, we sought to evolve our
fabrication approaches with new substrate materials to replace
the manual, serially fabricated single sensor built upon a
microscope slide with an efficient batch, parallel fabrication
process based on semiconductor industry models.
Here, we demonstrate a second generation, wafer-scale lab-on-
a-chip design and fabrication process for mitochondrial bioener-
getic measuring which is compatible with microfabrication
technology. This product is much more efficient to produce
and proves to have significantly higher reproducibility and
durability than the first generation model. We use industry
standard 499 silicon wafer as the substrate along with a new
membrane transfer technique. Changes in the mitochondrial
membrane potential of isolated mitochondria from the estab-
lished human cell lines Heb7A and 143B and from mouse muscle
tissue are evaluated in response to treatments with known
modulators of mitochondrial function. The sensor is validated by
taking the measured TPP+ concentration, converting into Dym
and calibrating against the theoretical values. This latest sensor
model improves upon all of the functional parameters of the
previous version, is capable of higher throughput analysis and,
importantly, is much more time and cost-effective to fabricate.
This lays the foundation for low cost, high throughput screening
of bioenergetics and metabolism in an on-chip format.
2 Methods
Fabrication steps
The microfabrication process is schematically depicted in Fig. 1.
A 499 bare silicon wafer (Boron doped P-type) was used as the
device substrate to allow compatibility with standard semicon-
ductor wafer-scale microfabrication technologies. The wafers
were treated with boiling piranha solution (3 : 1 = sulfuric acid:
DI water) for an hour followed by an organic solvent clean, then
rinsed with copious DI water. Thin films of Ti (50 nm) and Ag
(1.5 mm) were deposited using e-beam evaporation. The silver
film was lithographically patterned into electrodes using Shipley
1827 photoresist (Fig. 1 (a)). Wet etching was carried out using a
silver etchant made of 1 : 1 mixture of nitric acid and DI water
followed by Ti etching. The patterned silver electrodes were
chlorinated chemically by dropping 50 ml of 0.1 M FeCl3
solutions onto the electrode area, situated within the inner
Fig. 1 Schematic diagrams of microfabrication steps and the fabricated device. (a) Silver thick film deposition and patterning into electrode arrays on
a 499 Si wafer. (b) Chlorination of silver to make Ag/AgCl on the sensing areas. (c) Assembly of the 1st PDMS layer with microfluidic channels. (d)
TPP+ selective membrane transfer by flipping over the thin PDMS layer with cured membranes. (e) Photograph of the constructed device (inset,
showing a sensing chamber and access holes) and one complete set of six sensors manufactured in a batch, parallel process on a single 499 Si wafer.






































































electrolyte chamber, for 40 s at room temperature to create
Ag/AgCl electrodes (Fig. 1 (b)). Three layers of silicone rubber
(PDMS) were prepared separately by soft lithography. The first
layer has a microfluidic channel (400 mm 6 50 mm) to contain
the 10 mM TPP+ inner filling solution needed for the ion
selective sensing. These microfluidic channels were produced by
soft lithography with a thick negative photo resist (SU-8) mold
to keep the volume of the inner filling solution constant
compared to the hand-cut L-shaped reservoirs from our previous
reported sensor (Fig. 1 (c)). A 2 mm hole was drilled through the
center of the microfluidic channel to provide an interface
between the inner filling solution and the medium in the sensing
chamber through the ion selective membrane. The TPP+ ion
selective (IS) membrane solution was prepared with a mixture of
4.4 mL of tetrahydrofuran (THF) and dioctyl phthalate, 0.15 g
of polyvinyl chloride (PVC), and 6 mg of precipitation of
tetraphenylboron (Na+TBP2)12, and transferred onto a PDMS
layer by a new transfer technique (described below). To
streamline the fabrication process, we utilized a commercial,
leakage-free Ag/AgCl reference electrode (Warner Instruments)
and fabricated only the working electrode with the IS membrane.
In order to create reproducible membranes and ensure their
secure, wrinkle-free bonding with the underlying PDMS layer,
we developed a transfer method in which the IS membranes are
first prepared and cured on a separate PMDS scaffold before
being positioned and deposited on the chip. As depicted in Fig. 1
(d), a clean 2 mm thick PDMS scaffold was first aligned atop the
first PDMS layer, such that the open 2 mm center holes of six
microfluidic channels are visible from above. 30 mL of freshly
prepared ion selective membrane solution was then carefully
dropped onto the scaffold to correspond to the position of the
channel holes underneath. These were allowed to cure overnight
at room temperature. The following day, the scaffold was flipped
over, carefully positioned so the cured IS membranes fell within
the chamber holes, and gently pressed out for 5–10 min. This
resulted in intact IS membranes that were completely and
accurately transferred into position without wrinkles. We also
tried this transfer method at elevated temperature (y 60 uC) in a
hot oven, assuming that the membrane would be more pliable
and allow for easier transfer. Although the transfer was
successful, we found that the high-temperature treated mem-
branes did not exhibit proper responses to changes in [TPP+]. We
believe this is because the sensitivity of the IS membrane is a
non-linear function of temperature (data not shown). The
remaining two PDMS layers were aligned and assembled
together manually under a stereomicroscope. The bottom
microfluidic channel was filled with 10 mM TPP+ through the
access holes using a micropipette. The completed mitochondrial
lab-on-a-chip device in Fig. 1 (e) shows an array of 6 fully
manufactured sensors, with three layers of PDMS constructed
on a 499 silicon wafer. The inset reveals the components of the
chip including the bottom microfluidic channel with its access
holes and the open 80 mL circular sensing chamber.
To summarize, the advantages of this second generation
technology over the first generation include 1) A Si 499 wafer
process (rather than microscope slides), 2) Lithographically
defined PDMS microfluidic channels (as opposed to hand cut),
3) Batch compatible, transfer process for membrane assembly
(rather than manual membrane glue in place), and 4) A batch,
completely automatable, parallel manufacturing process that can
be scaled up to multiple devices per wafer) as opposed to
manual, serial assembly of each device component by compo-
nent. We now turn to the performance of the improved devices.
Results and Discussion
Characterization
The experimental set-up for the sensor calibration and measure-
ment is shown in Fig. 2. One of the patterned working electrodes
(Ag/AgCl) was connected to a digital multimeter (Agilent
34401A, input impedance setting = 10 GV) along with a
commercial leakage-free Ag/AgCl reference electrode (Warner
Instruments). A computer installed with LabView was linked to
the digital multimeter for data acquisition via a GPIB interface
(National Instrument, GPIB-USB-HS). The acquired data was
analyzed and plotted using Igor Pro (WaveMetrics).
The sensor was primed for use by filling the sensing chamber
and underlying microfluidic chamber with 10 mM TPP+ solution
overnight to activate the TPP+ IS membrane. The next day, the
inner filling solution was replaced with care taken to prevent
bubble formation which could create an open circuit against the
IS membrane and signal-reading errors. The sensing chamber
was rinsed with DI water and respiration buffer (refer to
supplemental information for composition) 3 times before filling
with fresh respiration buffer. The sensor was extensively
characterized using a 5-point calibration curve with TPP+
concentrations ranging from 0.3 mM to 600 mM. The potential
difference between the reference and working electrodes was
monitored while incrementally increasing the TPP+ concentra-
tions within the sensing chamber.
Fig. 2 (c) shows two calibration curves measured before and
after a typical mitochondrial measurement (see below) and
demonstrates the sensors reproducibility, durability, and small
drift between experiments. The insert plot shows the signal
stabilizing just a few seconds following each successive addition
of TPP+ (arrows) which marks a 60% faster response time
compared with our original sensor without its tapering large
signal spikes. TPP+ concentrations were plotted logarithmically
to reveal the linear relationship between concentration and IS
electrode (ISE) potential (mV) as predicted by the Nernst
equation. Since our experimental concentration range is between
5 and 10 mM, we typically perform a 2-point curve fit between
our 2nd and 3rd calibration points (3 mM and 30 mM
respectively). These measurements of ISE potential were used
to determine sensor variation using the following equation:
(VISE = J * ln[TPP
+]+K), (2)
where VISE is the measured ISE potential, and J and K are the
two calibration coefficients.
An important issue is the statistical variation among sensors,
which we now address. Fig. 2 (d) illustrates the statistical data from
21 separate calibration curves performed on eight different devices.
The J and K coefficients of variation represent the ratio of the
standard deviations to the averages which, in our hands, resulted in
values of # 18% and # 16%, respectively. This includes the effects
of both device-to-device variations, as well as variations from run-
to-run within one device. This narrow data distribution indicates






































































good reproducibility of the sensor response and a small device-to-
device variation. This is an improvement over our previous
devices[15] where the slope and offset from both sources of error
(device-to-device and run-to-run) varied by a much larger amount,
specifically # 25% and # 82% for J and K equivalent, respectively,
and indicates the significance of developing a wafer scale
manufacturing process. While excellent, this variation in calibration
coefficients may still require a careful calibration before each
measurement for some envisioned assays that require high accuracy,
an issue we hope to address in future generations of our chips.
Mitochondrial membrane potential measurement
As a demonstration with known cell lines, a mitochondrial
membrane potential assay was performed in respiration buffer at
room temperature using isolated mitochondria prepared from
human cell lines, including Heb7A and 143B TK-, and also from
mouse liver (Isolation protocols given in supplemental informa-
tion). During the measurement, the isolated mitochondria were
maintained on ice to prevent degradation. For each individual
sample, the TPP+ concentration traces were monitored before
and after the addition of mitochondria to establish a basal
‘‘resting’’ potential. Then, changes in the mitochondrial mem-
brane potential were recorded as OXPHOS complex I substrates
(pyruvate and malate) and ADP were added to the sensor
chamber. These measurements were converted to membrane
potential using a procedure similar to our previous publication11
(discussed in supplemental information).
In order to allow for improved quantitative measurements of
the membrane potential of various cell lines, we developed a
Fig. 2 (a) Schematic of experimental set-up showing the sensing chamber, the sensor connected to the external reference electrode, and one of the
electrode pads connected to a multimeter which is linked to a computer installed with Lab View for data acquisition. (b) Photograph set-up. (c) 5-point
calibration curves performed before/after mitochondrial assays showing reproducibility of the sensor. The slope of the highlighted area was used for
data conversion (Inset: time trace of ISE potential response during the calibration, arrows showing additions of TPP+.) (d) Statistical variation of J and
K values from 21 separate calibrations from 8 separate devices.






































































procedure in which all of the initial starting concentrations and
volume of solution and mitochondria were the same from
experiment to experiment, the only variable being the cell line
that produced the mitochondria. We chose an initial concentra-
tion of 7.2 mM for all the experiments, allowing for the same
initial starting point (prior to the introduction of mitochondria)
for all experiments. Using this technique, the initial value of
TPP+ was always known, and only changes in TPP+ were
needed. Thus, for the calibration, only the logarithmic slope of
the TPP+ vs. VISE curve was important. In an experiment where
the TPP+ vs. VISE curve was measured immediately before and
immediately after the experiment, the values of J changed by
y 15% (20.8 vs. 17.5 mV for J). In our experiments, we used only
the logarithmic slope (J21) to determine the value of TPP+ after
introduction of the mitochondria. More on the error analysis will
be presented below.
A representative result from a mitochondrial membrane
potential experiment is shown in Fig. 3 with [TPP+] values
obtained from the calibration curve conversion. After adjusting
the chamber working concentration of TPP+ to 7.2 mM, 5 mL of
150 ng mL21 freshly isolated mitochondria were introduced into
the 80 mL sensing chamber. Our experimental working concen-
tration, 10 ng mL21, is three orders of magnitude less than is
needed by conventional assays.12,13 The chamber solutions were
mixed gently three times using a micropipette and the trace was
allowed to stabilize and remain constant showing that the
solution is thoroughly mixed and no further diffusion occurred
due to the incomplete mixing during the measurement (data not
shown). Upon introduction of mitochondria, mitochondria
quickly absorbed TPP+ according to their Dym leading to
decrease in [TPP+] in the sensing chamber.
In our experiments, the addition of 5 mL of solution containing
mitochondria would lower the TPP+ concentration (even in the
absence of mitochondria) by about 0.5 mM. Because of the
membrane potential, there is an additional reduction in [TPP+]
due to uptake by the mitochondria. In Fig. 4, we plot the
relationship (eq. 1S in supplemental information) of the inferred
membrane potential to the measured [TPP+] concentration
change due to the mitochondria Dym.
To test functional activities of complex I by adding the
OXPHOS substrates, pyruvate and malate (P/M) were added, to
stimulate the active shuttling of protons out of the mitochondrial
matrix. This resulted in an increase in the magnitude of Dym,
thus diffusion of TPP+ into the matrix, resulting in a decrease in
[TPP+] in the medium. Indeed, the response to P/M was
instantaneous and stabilized to reveal a drastically decreased
[TPP+] by 1.5 mM in the sensing chamber. Once these data were
collected, we wanted to ensure the viability of our mitochondria
to validate that the TPP+ efflux is active and not merely due to
defunct OXPHOS machinery, degraded membranes, etc. To that
end, we added ADP to take advantage of the fact that OXPHOS
complex V (ATP synthase) utilizes the Dym to convert ADP to
ATP. Accordingly, we detected the increase of TPP+ ions in the
chamber, indicating a partial depolarization of the Dym which
was used to drive ATP synthesis. Due to the physical effect of
manual injections using a micropipette, signal noise was
recorded as scattered data when injections were performed.
This could be eliminated by employing an automated fluidic
perfusion system in future designs.
The same series of measurements with mitochondria from
Heb7A and mouse muscle cell lines were performed and
compared. The amount of mitochondria and chemicals as well
as the sequence of injections remained the same to avoid
variations from assay to assay. Drops of [TPP+] after addition of
mitochondria, and the corresponding Dym values are plotted in
Fig. 5 which were obtained from 6 different assays. As expected
from prior studies of mitochondrial bioenergetics, Dym of
mitochondria from mouse skeletal muscle showed the largest
value among other cell lines indicating the vibrant activity of the
skeletal muscle tissue. (Run to run variations are attributed to
sensor drift, to be discussed below in further detail.) The
membrane potential of Heb7A was slightly higher than that of
143b. Overall the results of the mitochondrial assays were
consistent with the results of prior studies.12,14
We now turn to a detailed error analysis of our procedure. In
our experiments, the statistical variation (as a function of time)
Fig. 3 Measurement of [TPP+] with isolated mitochondria from 143B
TK- osteosarcoma cells. Vertical arrows indicate successive addition of
5 mL of 150 ng mL21 isolated mitochondria, 10 mL of 1 M pyruvate/0.5 M
Malate and 1mL of 10 mM ADP. See text for discussion.
Fig. 4 Conversion of measured [TPP+] into Dym.






































































when the sensor was stable was quite low. For example, the
standard deviation of the measured ISE potential for the time
trace shown in Fig. 3 in the stable region between t y 500 s and
t y 600 s is only 50 mV. In this experiment, for this trace, this
corresponds to a standard deviation of 0.02 mM in the value of
[TPP+]. The inferred value of Dym has a standard deviation of
only 0.5 mV. Each point was integrated for y 1 s. (For a 10 ms
integration time, this would correspond to a 5 mV standard
deviation on the inferred membrane potential.) This corresponds
to an order of magnitude improvement over our first generation
technology.11 In addition to rapid, random fluctuations due to
statistical variations, we also observed permanent, progressive
changes in the measured [TPP+] values, which we attribute to the
actual biochemistry of the mitochondria which respond on a
much longer time scale compared to the measurement time per
point of one second. Since we do not typically observe these long
term drifts during calibration without mitochondria (see e.g. the
inset of Fig. 2 (c)) we believe the time dependent behavior we
observe is not due to the sensor technology itself. Indeed, this
demonstrates the ability of our technology to assay kinetic as
well as equilibrium bioenergetics.
Drift of the calibration during the measurement is more
significant, and we address this issue now. In principle, the
histograms of Fig. 2 provide a complete quantification of this
drift between calibrations and devices. As discussed earlier, it is
possible to improve on this error by performing calibrations just
before and after the experiment, and using identical conditions in
order to compare the behavior between devices. As discussed
above, the initial value of [TPP+] is known accurately, so that the
small changes from this initial value can be determined only from
small changes in the measured sensor voltage and the (logarith-
mic) slope (J21) of the calibration curve, the offset being less
important because only small changes about the known, initial
value are considered. For the example experiment in Fig. 3, the
introduction of mitochondria into the chamber changed the
value of [TPP+] by, at most, 1 mM. Since the initial value is
known with low error, and the (logarithmic) slope is determined
with a drift of less than 15% during the measurement (worst case,
see above), the value of the change in the value of [TPP+] is
known to within at worst y 0.1 mM. The error bar due to the
uncertainty in the slope J is the dominant error, and indicated in
Fig. 5. (Note that due to the non-linear relationship between the
measured ISE potential and the inferred value of [TPP+], the
error in [TPP+] gets approximately linearly worse as the change
in [TPP+] increases from 0 to 1 mM. We have determined
numerically that the error is at most ¡ 0.12 mM error for a 1 mM
drop in [TPP+] on introduction of mitochondria, and less for
smaller drops in [TPP+], by calculating [TPP+] for different
values of J21 and determining the worst case error at each value
of inferred TPP+ drop.) In order to relate the calibration drift
component of this [TPP+] error to an error in the inferred value
of Dym, we use eq. 1S of supplemental information. As can be
seen in Fig. 4, this conversion is non-linear, so the error
conversion will depend on the specific parameters of the
experiment. In our case, this still allows an error smaller than
y ¡ 10 mV for the determination of high values of Dym. This
error increases as the values of Dym decreases from 180 mV.
These parameters will continue to allow studies on the relative
value of Dym between different cell lines. This can thus be a
powerful tool for the accurate investigation of mitochondrial
membrane potential from a variety of cell lines where sample size
is limited, such as clinical biopsies or embryonic stem cells.
The sensors developed here remained completely functional for
longer than three months and exhibited reproducible responses for
over 40 assessments without replacing the TPP+ ion selective
membrane or Ag/AgCl electrodes. For further improvement on
sensor performance and the stability, there are three possible
avenues. First, a temperature controller to control medium
temperature would enable improved stability of the calibration
curve and also bioenergetics studies, which are important to carry
out at a known (rather than ambient) temperature. Second, an on-
chip stirrer could be integrated into the chamber for continuous
mixing during the assay. Lastly, a sensor equipped with an
automated sample perfusion system with an encapsulated sensing
chamber would provide better stability and measurements com-
pared to a manual sample injection by a micropipette.
Conclusions
A wafer-scale fabrication process for a TPP+ ion selective microsensor
for mitochondrial membrane potential assays has been developed and
demonstrated. The newly designed process includes the new membrane
transfer method which is compatible with microelectronic fabrication
techniques resulting in high yield and high throughput process by
integrating 6 devices into a single wafer. Further improvement is possible
with more effort to increase the number of devices on a single wafer. Due
to the improved bonding condition between the TPP+ ion selective
membrane and the bottom PDMS layer, the devices showed structural
stability and robustness over an extended period of time (. 3 months)
with nominally identical sensitivity to changes in [TPP+]. Due to the
system design, in the future it is feasible to run several assays in parallel at
the same time for high throughput studies. This will allow a cost-effective
method to mass-produce miniaturized mitochondrial assay chips, which
are candidates to replace the current costly systems installed with large,
traditional sensing chambers. For these reasons, our system can find
various applications in the emerging field of mitochondrial bioenergetics.
Fig. 5 Data comparisons of drops in [TPP+] due to mitochondrial
uptake measured right after addition of mitochondria. Right axis shows
calculated Dym of isolated mitochondria. Data are from three different
cell lines (143b, mouse muscle, Heb7A). Error bars are due to calibration
uncertainty of the ISE electrode potential to [TPP+].
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